AS
The startup develops specialized delivery systems for prostacyclin therapy aimed at improving treatment outcomes for patients with pulmonary arterial hypertension (PAH). By optimizing the administration of this critical medication, the company enhances patient access to effective cardiovascular treatments.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops specialized delivery systems for prostacyclin therapy aimed at improving treatment outcomes for patients with pulmonary arterial hypertension (PAH). By optimizing the administration of this critical medication, the company enhances patient access to effective cardiovascular treatments.